0000000000367304

AUTHOR

L Salsa

showing 6 related works from this author

Outbreak of Salmonella enteritis bongori 48:z35:- in Sicily.

2003

Salmonella bongori 48:z 35 :- was first isolated from a lizard in Chad in 1966 and was classified as a biochemically atypical strain of the subgenus I of Kauffmann. Successively, some additional strains with different antigenic formulas but similar bioche

Salmonella bongoriEpidemiologyVirologyparasitic diseasesPublic Health Environmental and Occupational HealthSalmonella enteritisOutbreakBiologySubgenusbiology.organism_classificationVirologyMicrobiologyEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
researchProduct

Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005–2006 in Palermo, Italy

2009

Abstract Objectives Respiratory Syncytial Virus (RSV) is the leading cause of hospitalization for lower respiratory tract infections (LRTI) in young children worldwide. We evaluate the epidemiological and clinical patterns of RSV infection in infants hospitalized for LRTI in in Palermo, South Italy, Sicily. Methods We collected the demographic details of infants hospitalized to G. Di Cristina Children's Hospital in Palermo for LRTI between November 2005 and May 2006. We also included all cases occurred in newborns hospitalized in the Neonatal Intensive Care Unit (NICU) Of Palermo. Results During the studied period, 335/705 hospitalized infants for LRTI were enrolled in the study. The trend …

Pediatricsmedicine.medical_specialtyNeonatal intensive care unitSettore MED/17 - Malattie InfettiveRespiratory tract infectionsMaternal and child healthbusiness.industryvirusesResearchlcsh:RJ1-570Infantlcsh:Pediatricsmedicine.diseaseVirusrespiratory tract diseasesHospitalizationLower Respiratory Tract InfectionLower respiratory tract infectionEpidemiologymedicineRespiratory Syncytial VirusRespiratory systembusinessItalian Journal of Pediatrics
researchProduct

PLASMA LEVELS OF TUMOR NECROSIS FACTOR a AND INTERFERON g IN SICILIAN CHILDREN WITH MEDITERRANEAN SPOTTED FEVER

1997

The plasma levels of tumor necrosis factor-alpha and interferon-gamma were measured in 53 consecutive children with serologically confirmed Mediterranean spotted fever and were found to be increased during the acute phase compared with the convalescent phase (tumor necrosis factor-alpha mean 32.17 vs. 4.12 pg/ml, P < 0.0001; interferon-gamma mean 84.17 vs. 2.65 pg/ml, P = 0.0006). Plasma levels of both cytokines were higher in patients with a typical exanthema rather than those with a very mild or no exanthema; tumor necrosis factor-alpha levels were significantly lower in the latter (tumor necrosis factor-alpha 32.17 vs. 9.85 pg/ml, P < 0.0001; interferon-gamma 84.17 vs. 38.14 pg/ml, P = 0…

Malemedicine.medical_specialtyAdolescentmedicine.medical_treatmentClinical BiochemistryInflammationBiologyBoutonneuse FeverInterferon-gammaInternal medicinemedicineHumansInterferon gammaChildSicilyHematologyTumor Necrosis Factor-alphaSodiumInfantmedicine.diseaseSpotted feverBoutonneuse feverC-Reactive ProteinEndocrinologyRickettsiosisCytokineChild PreschoolImmunologyFemaleTumor necrosis factor alphamedicine.symptommedicine.drug
researchProduct

Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy

2004

Visceral leishmaniasis (VL) is endemic in areas bordering the Mediterranean Sea (Spain, Italy, France, Greece, Morocco, Tunisia) where it is caused by Leishmania infantum and is transmitted by the bite of a hematophagous sandfly belonging to Phlebotomus spp.; the dog constitutes the main reservoir of infection. Two cases of VL in immunocompetent children are described. Both patients lived in endemic areas for leishmaniasis (Sicily) and at admission were febrile, pale and had splenomegaly. In both patients anti-leishmania antibodies were present and a definitive diagnosis was confirmed by demonstration of leishmania parasites by microscopy or polymerase chain reaction (PCR) in the bone marro…

Visceral leishmaniasis immunocompetent children
researchProduct

Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial

2001

Fifty-one children with Mediterranean spotted fever (MSF) were randomized to receive either clarithromycin, 15 mg/kg/ day orally in 2 divided doses, or chloramphenicol, 50 mg/ kg/day orally in 4 divided doses, for 7 days. Mean time to defervescence was 36.7 h in the clarithromycin group and 47.1 h in the chloramphenicol group (P = .047). Clarithromycin could be an acceptable therapeutic alternative to chloramphenicol and to tetracyclines for children aged <8 years with MSF.

Microbiology (medical)Malemedicine.medical_specialtyBoutonneuse FeverGastroenterologylaw.inventionRandomized controlled trialOral administrationlawClarithromycinInternal medicineClarithromycinmedicineHumansChildAntibacterial agentclarithromycin Mediterranean spotted feverbusiness.industryChloramphenicolmedicine.diseaseSpotted feverSurgeryAnti-Bacterial AgentsBoutonneuse feverInfectious DiseasesRickettsiosisChloramphenicolChild PreschoolFemalebusinessmedicine.drug
researchProduct

Respiratory syncytial virus infection in a Sicilian pediatric population: Risk factors, epidemiology, and severity

2008

Respiratory syncytial virus (RSV) is the leading cause of hospitalization for lower respiratory tract infections (LRTIs) in young children worldwide. This study evaluated the epidemiological and clinical patterns of RSV infection in infants hospitalized for LRTIs in Sicily. Over a 7-month period (October 1, 2005 to April 30, 2006), all children 6 months old, with a gestational age (GA) of >36 weeks, with a birth weight of >2.50 g, with previous hospitalizations due to LRTI, with smokers in the household, and with a history of breast-feeding (p < 0.05 for each). RSV infection was associated with a higher likelihood to be admitted to neonatal intensive care units and to longer hospitalization…

MalePulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtySettore MED/17 - Malattie InfettiveBirth weightRespiratory Syncytial Virus InfectionsTobacco smokeVirusSettore MED/38 - Pediatria Generale E SpecialisticaRisk FactorsIntensive careEpidemiologymedicineHumansBreast-feeding Hospitalization Infants Risk factors RSV infection Severity Trend seasonalImmunology and AllergyRespiratory systemSicilyRespiratory tract infectionsbusiness.industryInfant NewbornInfantGestational ageGeneral MedicineLogistic ModelsRespiratory Syncytial Virus HumanFemalebusinessAllergy and Asthma Proceedings
researchProduct